We have located links that may give you full text access.
E-029 WEB Flow Disruption: Preliminary Results from WEBCAST trial.
Journal of Neurointerventional Surgery 2014 July
BACKGROUND AND PURPOSE: WEBCAST is a European study dedicated to the evaluation of the feasibility, safety, and efficacy of endovascular treatment with WEB of intracranial aneurysms.
MATERIALS AND METHODS: The study was conducted in 10 European centers. Inclusion criteria were aneurysms located at internal carotid artery bifurcation, middle cerebral artery, basilar artery, and anterior communicating artery with a neck ≥4 mm and a dome to neck ratio ≥ 1. Recanalized aneurysms were not included. Complications and safety data were independently evaluated. Aneurysm occlusion was evaluated at 6 months with DSA by an independent core lab. Aneurysm occlusion was evaluated stable at 6 months in case of complete occlusion, no modification or improvement of the occlusion (versus post-operative occlusion), and no retreatment was performed or foreseen.
RESULTS: Fifty-one patients (36 females and 15 males) with 51 aneurysms were included between December 2011 and February 2014. Age was between 33 and 75 years (55.6 ± 1.5 years). Forty-eight aneurysms were unruptured and 3 ruptured. Aneurysm location was middle cerebral artery (28 aneurysms), basilar artery (12 aneurysms) internal carotid artery (6 aneurysms), and anterior communicating (5 aneurysms). The feasibility, safety, and efficacy of the treatment is analyzed.
CONCLUSION: WEBCAST is the first prospective, multicenter trial evaluating the treatment of intracranial aneurysms with WEB Aneurysm Embolization System. Preliminary results are presented.
DISCLOSURES: L. Pierot: 2; C; Sequent. L. Spelle: None. V. Costalat: None. I. Szikora: None. J. Klisch: None. D. Herbreteau: None. M. Holtmannspoetter: None. W. Weber: None. T. Liebig: None. C. Cognard: None. A. Bonafé: None. J. Moret: None. J. Byrne: None. A. Molyneux: None.
MATERIALS AND METHODS: The study was conducted in 10 European centers. Inclusion criteria were aneurysms located at internal carotid artery bifurcation, middle cerebral artery, basilar artery, and anterior communicating artery with a neck ≥4 mm and a dome to neck ratio ≥ 1. Recanalized aneurysms were not included. Complications and safety data were independently evaluated. Aneurysm occlusion was evaluated at 6 months with DSA by an independent core lab. Aneurysm occlusion was evaluated stable at 6 months in case of complete occlusion, no modification or improvement of the occlusion (versus post-operative occlusion), and no retreatment was performed or foreseen.
RESULTS: Fifty-one patients (36 females and 15 males) with 51 aneurysms were included between December 2011 and February 2014. Age was between 33 and 75 years (55.6 ± 1.5 years). Forty-eight aneurysms were unruptured and 3 ruptured. Aneurysm location was middle cerebral artery (28 aneurysms), basilar artery (12 aneurysms) internal carotid artery (6 aneurysms), and anterior communicating (5 aneurysms). The feasibility, safety, and efficacy of the treatment is analyzed.
CONCLUSION: WEBCAST is the first prospective, multicenter trial evaluating the treatment of intracranial aneurysms with WEB Aneurysm Embolization System. Preliminary results are presented.
DISCLOSURES: L. Pierot: 2; C; Sequent. L. Spelle: None. V. Costalat: None. I. Szikora: None. J. Klisch: None. D. Herbreteau: None. M. Holtmannspoetter: None. W. Weber: None. T. Liebig: None. C. Cognard: None. A. Bonafé: None. J. Moret: None. J. Byrne: None. A. Molyneux: None.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app